American Journal of Cardiology
Volume 98, Issue 8 , Pages 1053-1056 , 15 October 2006

Comparison of Body Mass Index Versus Waist Circumference With the Metabolic Changes That Increase the Risk of Cardiovascular Disease in Insulin-Resistant Individuals

Received 10 January 2006 ,Revised 8 May 2006 ,Accepted 9 May 2006.

References 

  1. Alberti KG, Zimmet PZ. Definition, diagnosis and classification of diabetes mellitus and its complications (Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation). Diabet Med. 1998;15:539–553
  2. Expert Panel on the Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive summary of the third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). JAMA. 2001;285:2846–2897
  3. Alberti KGMM, Zimmet P, Shaw J IDF Epidemiology Task Force Consensus Group. The metabolic syndrome–a new worldwide definition. Lancet. 2005;366:1059–1062
  4. Ford ES, Mokdad AH, Giles WH. Trends in waist circumference among U.S. adults. Obes Res. 2003;11:1223–1231
  5. American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care. 2004;27(suppl 1):S5–S10
  6. Centers for Disease Control and Prevention. The Third National Health and Nutrition Examination Survey (NHANES III 1988–94) Reference Manuals and Reports. Bethesda: National Center for Health Statistics; 1996;(CD-ROM)
  7. National Institutes of Health. Clinical Guidelines on the Identification, Evaluation, and Treatment of Overweight and Obesity in Adults: the Evidence Report. Bethesda: National Institutes of Health, United States Department of Health and Human Services; 1998;
  8. Pei D, Jones CN, Bhargava R, Chen YD, Reaven GM. Evaluation of octreotide to assess insulin-mediated glucose disposal by the insulin suppression test. Diabetologia. 1994;37:843–845
  9. Shen SW, Reaven GM, Farquhar JW. Comparison of impedance to insulin-mediated glucose uptake in normal and diabetic subjects. J Clin Invest. 1970;49:2151–2160
  10. Greenfield MS, Doberne L, Kraemer F, Tobey TA, Reaven GM. Assessment of insulin resistance with the insulin suppression test and the euglycemic clamp. Diabetes. 1981;30:387–392
  11. Pyorala K. Relationship of glucose tolerance and plasma insulin to the incidence of coronary heart disease: results from two population studies in Finland. Diabetes Care. 1979;2:131–141
  12. Castelli WP, Garrison RJ, Wilson PWF, Abbott RO, Kalonsdian S, Kannel WB. Incidence of coronary heart disease and lipoprotein cholesterol levels: the Framingham Study. JAMA. 1986;256:2385–2387
  13. Austin MA, Hokanson JE, Edwards KI. Hypertriglyceridemia as a cardiovascular risk factor. Am J Cardiol. 1998;81(suppl):7B–12B
  14. Facchini FS, Hua N, Abbasi F, Reaven GM. Insulin resistance as a predictor of age-related diseases. J Clin Endocrinol Metab. 2001;86:3574–3578
  15. Kissebah AH, Vydelingum N, Murray R, Evans DJ, Hartz AJ, Kalkhoff RK, et al. Relation of body fat distribution to metabolic complications of obesity. J Clin Endocrinol Metab. 1982;54:254–260
  16. Sparrow D, Borkan GA, Gerzof SG, Wisniewski C, Silbert CK. Relationship of fat distribution to glucose tolerance: results of computed tomography in male participants of the Normative Aging Study. Diabetes. 1986;35:411–415
  17. Bjorntorp P. Adipose distribution, plasma insulin, and cardiovascular disease. Diabete Metab. 1987;13:381–385
  18. Despres JP, Nadeau A, Tremblay A, Ferland M, Lupien PJ. Role of deep abdominal fat in the association between regional adipose tissue distribution and glucose tolerance in obese women. Diabetes. 1989;38:304–309
  19. Pouliot MC, Despres JP, Nadeau A, Moorjani S, Prud’homme D, Lupien PJ, et al. Visceral obesity in men: associations with glucose tolerance, plasma insulin, and lipoprotein levels. Diabetes. 1992;41:826–834
  20. Kissebah AH, Krakower GR. Regional adiposity and morbidity. Physiol Rev. 1994;74:761–811
  21. Gautier JF, Milner MR, Elam E, Chen K, Ravussin E, Pratley RE. Visceral adipose tissue is not increased in Pima Indians compared with equally obese Caucasians and is not related to insulin action or secretion. Diabetologia. 1999;42:28–34
  22. Tulloch-Reid MK, Williams DE, Looker HC, Hanson RL, Knowler WC. Do measures of body fat distribution provide information on the risk of type 2 diabetes in addition to measures of general obesity?. Diabetes Care. 2003;26:2556–2561
  23. Haffner SM, Stern MP, Mitchell BD, Hazuda HP, Patterson JK. Incidence of type II diabetes in Mexican Americans predicted by fasting insulin and glucose levels, obesity, and body fat distribution. Diabetes. 1990;39:283–299
  24. Wang Y, Rimm EB, Stampfer MJ, Willett WC, Hu FB. Comparison of abdominal adiposity and overall obesity in predicting risk of type 2 diabetes among men. Am J Clin Nutr. 2005;81:555–563
  25. Seidell JC, Cigolini M, Deslypere JP, Charzewska J, Ellsinger BM, Cruz A. Body fat distribution in relation to serum lipids and blood pressure in 38-year-old European men: the European fat distribution study. Atherosclerosis. 1991;86:251–260
  26. Folsom AR, Li Y, Pao X, Cen R, Zhang K, Lin X, et al. Body mass, fat distribution and cardiovascular risk factors in a lean population of south China. J Clin Epidemiol. 1994;47:173–181
  27. Sakurai Y, Kono S, Shinchi K, Honjo S, Todoroki I, Wakabayashi K, et al. Relation of waist-hip ratio to glucose tolerance, blood pressure, and serum lipids in middle-aged Japanese males. Int J Obes. 1995;19:632–637
  28. Takami R, Takeda N, Hayashi M, Sasaki A, Kawachi S, Yoshino K, et al. Body fatness and fat distribution as predictors of metabolic abnormalities and early carotid atherosclerosis. Diabetes Care. 2001;24:1248–1252
  29. Schmidt MI, Duncan BB, Watson RL, Sharrett AR, Brancati FL, Heiss G. A metabolic syndrome in whites and African-Americans. Diabetes Care. 1996;19:414–418
  30. Wang J, Thornton JC, Bari S, Williamson B, Gallagher D, Heymsfield SB, et al. Comparisons of waist circumferences measured at 4 sites. Am J Clin Nutr. 2003;77:379–384

 This study was supported by Grant 5 T32 HL07708 from the National Institutes of Health, Bethesda, Maryland, and Stanford Vascular Biology and Medicine Training, Stanford, California; and by Grant RR-00070 from the National Institutes of Health, Bethesda, Maryland.

PII: S0002-9149(06)01281-1

doi: 10.1016/j.amjcard.2006.05.025

American Journal of Cardiology
Volume 98, Issue 8 , Pages 1053-1056 , 15 October 2006

Article Tools